- MDVLQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
MedAvail (MDVLQ) CORRESPCorrespondence with SEC
Filed: 31 May 19, 12:00am
MYOS RENS TECHNOLOGY INC.
45 Horsehill Road, Suite 106
Cedar Knolls, New Jersey 07927
May 31, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attn: Sonia Bednarowski
Re: | MYOS RENS Technology Inc. |
Registration Statement on Form S-3 | |
File No. 333-230906 |
Dear Ms. Bednarowski:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, MYOS RENS Technology Inc. hereby requests acceleration of the effectiveness of the above-referenced Registration Statement so that it will become effective at 4:00 p.m. ET on Monday, June 3 2019, or as soon as practicable thereafter.
Very truly yours, | ||
/s/ Joseph Mannello | ||
Name: Joseph Mannello | ||
Title: Chief Executive Officer |